The most common concomitant gene mutations in MLL-PTD associated AML were FLT3-ITD, followed by DNMT3A mutation, RUNX1 mutation, IDH1/IDH2 mutation, and TET2 mutation. Here, IDH2 is linked to acute myeloid leukemia.